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Colonization of broiler chickens by the enteric pathogen Campylobacter jejuni is widespread and difficult to
prevent. Bacteriophage therapy is one possible means by which this colonization could be controlled, thus
limiting the entry of campylobacters into the human food chain. Prior to evaluating the efficacy of phage
therapy, experimental models of Campylobacter colonization of broiler chickens were established by using
low-passage C. jejuni isolates HPC5 and GIIC8 from United Kingdom broiler flocks. The screening of 53 lytic
bacteriophage isolates against a panel of 50 Campylobacter isolates from broiler chickens and 80 strains
isolated after human infection identified two phage candidates with broad host lysis. These phages, CP8 and
CP34, were orally administered in antacid suspension, at different dosages, to 25-day-old broiler chickens
experimentally colonized with the C. jejuni broiler isolates. Phage treatment of C. jejuni-colonized birds resulted
in Campylobacter counts falling between 0.5 and 5 log10 CFU/g of cecal contents compared to untreated controls
over a 5-day period postadministration. These reductions were dependent on the phage-Campylobacter com-
bination, the dose of phage applied, and the time elapsed after administration. Campylobacters resistant to
bacteriophage infection were recovered from phage-treated chickens at a frequency of <4%. These resistant
types were compromised in their ability to colonize experimental chickens and rapidly reverted to a phage-
sensitive phenotype in vivo. The selection of appropriate phage and their dose optimization are key elements
for the success of phage therapy to reduce campylobacters in broiler chickens.
Campylobacter jejuni and C. coli collectively account for the
majority of acute bacterial enteritis cases reported in the
United Kingdom and most of the developed world (12). More
than 80% of birds in the United Kingdom harbor these organ-
isms as a part of their normal intestinal flora (9, 26). Large
numbers of these bacteria are disseminated upon abattoir pro-
cessing and can be readily isolated from fresh chicken produce
(20). The consumption of undercooked poultry meat and the
cross-contamination of other foods in the preparation of poul-
try are significant risk factors in the transmission of campy-
lobacters to human beings (20). A contemporary risk assess-
ment has estimated that a log10 2.0 reduction in Campylobacter
numbers on retail chicken carcasses could reduce the fre-
quency of human campylobacteriosis by up to 30-fold (32). To
achieve this aim, intervention measures have focused on im-
proving farm biosecurity and/or the decontamination of poul-
try carcasses postslaughter.
Ideally, decontamination techniques should not change the
organoleptic or nutritional properties of the food. They should
also be safe, inexpensive, and acceptable to the public. At
present no single technique fits these criteria, although a num-
ber of different approaches to reduce Campylobacter carcass
contamination have been suggested (10).
Intervention strategies focused at the start of the food chain
(i.e., the broiler farm) are most likely to yield the greatest
reductions of Campylobacter contaminating retail poultry
meat. The upgrading of biosecurity has successfully produced
Campylobacter-free chickens, but these measures are expensive
and difficult to maintain. This is largely due to the susceptibility
of chickens to infection by Campylobacter and its ubiquity in
the environment (25). Moreover, unless increased biosecurity
is applied globally, the benefits of reducing Campylobacter on
some farms will be negated by cross-contamination from pos-
itive flocks at the abattoir (17). Campylobacters are usually first
detected in broiler house chickens when they are ca. 2 to 3
weeks old (25). The principle site of colonization is the gas-
trointestinal tract, in particular the ceca, small intestine, large
intestine, and cloaca (6). Although it is generally accepted that
campylobacters have evolved to rapidly and efficiently colonize
the avian gut, some strains have been identified as poor colo-
nizers (23, 31). Mutations in certain genes, for example, those
with functions associated with motility, capsule formation, che-
motaxis, and microaerobic respiration, result in a reduced abil-
ity to colonize chickens (16, 21). Models of colonization rele-
vant to the hypothesis being tested are therefore of vital
importance in studies aimed at the reduction of campy-
lobacters in the food chain (26).
Another potential method of controlling campylobacters at
the farm level is by competitive exclusion (CE). This technique
has been successfully used to control Salmonella, but CE trials
with Campylobacter have produced mixed results (26). Protec-
tion has been demonstrated with a strain of layer hen leading
to the conclusion that CE effect was strongly dependent on
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bird variety to which it was applied (24). The success of vac-
cination in controlling Salmonella in United Kingdom layer
flocks has prompted studies into a similar treatment for
Campylobacter. Although this is a feasible strategy, toward
which some progress has been recently reported (43), no such
vaccine is currently available for commercial application (re-
viewed in reference 26).
Bacteriophages are naturally occurring predators of bacteria
that are ubiquitous in the environment. Most bacterial species
have their own specific bacteriophages, and campylobacters
are no exception. Campylobacter-specific bacteriophages have
been isolated from various sources including pig manure, ab-
attoir effluents, sewage, and broiler chickens (2, 15, 22, 35).
Some of these bacteriophages have been characterized to form
the basis of the United Kingdom phage typing scheme (13, 34).
Bacteriophages have been applied as a decontamination tech-
nique to reduce campylobacters on poultry meat under exper-
imental conditions (3, 14). Since campylobacters are unable to
multiply under refrigeration conditions, the phages may infect
hosts on the surface of poultry meat but are unable to complete
their replication cycle until environmental conditions are per-
missive for metabolic activity of their host. Whether the con-
sumption of bacteriophage-infected campylobacters on con-
taminated meat would provide protection from enteric disease
is unknown. The use of bacteriophages to reduce the numbers
of campylobacters entering the food chain at farm level is a
potentially useful intervention strategy (2), where reductions in
numbers of campylobacters in chickens could lead to a mea-
surable reduction in carcass contamination.
Bacteriophages are readily isolated from poultry excreta
and, as a consequence, their potential therapeutic application
to animals would not introduce any new biological entity into
the food chain. A growing number of studies have successfully
used phages to treat animal diseases (reviewed in references 5
and 29). These include applications to treat Salmonella (7, 37)
and Escherichia coli (4, 18, 19) infections of young chickens.
The use of phages to control Campylobacter in chickens di-
verges from these previous studies since campylobacters are
considered natural commensals, not pathogens, of poultry spe-
cies. Campylobacters colonize the chicken intestine to a high
density and as such are a promising target for phage therapy.
Concerns have been raised that campylobacters will simply
become resistant to bacteriophages rendering this strategy in-
effective in the long term (5). Bacteria rapidly mutate to be-
come resistant to bacteriophages in vitro on laboratory media
(1). However, unlike bacterial resistance to static chemother-
apeutic agents such as antibiotics, bacteriophages constantly
evolve to circumvent host barriers to infection. This leads to an
evolutionary balance that allows both host and prey to prolif-
erate.
Although Western countries have been slow in adopting
bacteriophage therapy, primarily because of the antibiotics in-
dustry and a paucity of consistent evidence of phage efficacy,
former Soviet Union countries have embraced the technology
(41). The failures of Western scientists to achieve consistent
results may have resulted from a general lack of understanding
of phage biology and replication dynamics. Phage replication is
critically dependent on the density of bacteria. There is pre-
dicted to be a distinct threshold above which phage numbers
increase and below which they decrease, termed the phage
proliferation threshold (29). The outcome of phage therapy
also depends on the various life history parameters, including
the inoculum size, and the inoculum timing (28, 42).
Here we describe the use of Campylobacter bacteriophages
to reduce numbers of campylobacters in experimentally in-
fected chickens and the optimization of the phage therapy
regime. Targeted intervention measures to reduce colonization
require that a suitable colonization model be established to
ensure that differences in the colonization potential of Campy-
lobacter strains do not affect the outcome (26). We also de-
scribe in vitro experiments of bacteriophage and host prolifer-
ation as a basis for the use of the phages and host in model
chicken studies. Finally, we describe studies on the acquisition
of phage resistance by the test campylobacters exposed to
phage in the chicken intestine and the implications of this for
the use of phage therapy to control campylobacters.
MATERIALS AND METHODS
Bacterial strains and growth media. Campylobacters were isolated and iden-
tified from broiler chicken excreta, free-range chicken excreta and from the
surface of poultry meat by direct plating on cefoperazone charcoal deoxycholate
agar (mCCDA) selective medium (LAB 112 [Lab M, Bury, United Kingdom];
with cefoperazone and amphotericin B supplement from Pro Lab Diagnostics,
Neston, United Kingdom) using standard techniques. The isolates and reference
strains were cultured on horse blood agar (blood agar base no. 2 CM0271 [Oxoid,
Basingstoke, United Kingdom] with 5% defibrinated horse of blood [TCS, Buck-
ingham, United Kingdom] added) under microaerobic conditions (5% O2, 5%
H2, 10% CO2, and 80% N2 produced by the evacuation and replacement tech-
nique) at 42°C for 24 h. Strains of Campylobacter were stored at 80°C in
Microbank storage beads (Pro Lab Diagnostics).
Experimental birds. Commercial Campylobacter-free male Ross broiler chick-
ens were obtained as hatchlings (PD Hook, Oxfordshire, United Kingdom).
Birds were housed in a controlled environment in individual pens under strict
conditions of biosecurity. To ensure that the experimental birds remained free of
naturally occurring infection, feces and cloacal swabs were taken each day and
tested for Campylobacter by direct plating on mCCDA agar and for Salmonella
by enrichment in Rappaport-Vassiliadis soya peptone broth (CM 866; Oxoid)
then plating on xylose-lysine desoxycholoate agar (CM 469; Oxoid).
The chickens were killed and the ceca and upper (proximal small intestine)
and lower intestines of the birds were first separated by ligature and then
removed by sterile dissection; the lumenal contents were collected for Campy-
lobacter and bacteriophage isolation. Essential organs (liver, pancreas, heart, and
kidney) were also dissected and homogenized to examine whether the bacteria or
bacteriophages could be found in other tissues.
Chicken colonization model. Broiler chicken C. jejuni isolates HPC5 and
GIIC8 were suspended in phosphate-buffered saline (PBS; BR14a; Oxoid) and
diluted to produce a range of colonization doses from log10 2.7 to 7.8 CFU (n 
four birds per dose tested). Each chicken was dosed with 1 ml of bacterial
suspension in PBS or PBS alone for the controls by oral gavage at 20 to 22 days
of age. Chickens were killed after 48 h, and the campylobacters were enumerated
from the contents of the ceca and upper and lower intestines. Colonization levels
were recorded as the log10 CFU per gram of intestinal contents for each dose of
the C. jejuni isolate administered. Persistence over a longer period was examined
by using an established dose of log10 8 CFU in 1 ml of PBS to colonize chickens;
thereafter, groups of birds (n  5) were killed at 24-h intervals and the campy-
lobacters present in their intestinal contents were enumerated as stated above.
Enumeration of campylobacters. Serial dilutions of cecal contents and upper
and lower intestine contents were made in maximum recovery diluent (CM0733;
Oxoid) and enumerated using the Miles and Misera technique on mCCDA agar
with additional agar (L13; Oxoid) to a total of 2% added to reduce swarming.
Plates were incubated under microaerobic conditions at 42°C for 48 h before
typical Campylobacter colonies were counted.
PFGE of SmaI digests of genomic DNA. In order to ensure that no contami-
nating campylobacters had infected the birds in the containment facility, pulsed-
field gel electrophoresis (PFGE) was carried out (8) on SmaI-digested DNA and
compared to the known profiles of the test strains.
MLST of Campylobacter isolates. Selected isolates were also analyzed by using
a multilocus sequence typing (MLST) scheme (11) to ensure single strain colo-
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nization. Analysis of the sequence alleles was performed with reference to the C.
jejuni MLST database (http://mlst.zoo.ox.ac.uk).
Bacteriophage selection, growth, and enumeration. Bacteriophages were iso-
lated from ceca and upper and lower intestines as previously described (2, 8).
Briefly, a 10% suspension of intestinal contents was prepared in SM buffer (50
mM Tris-HCl [pH 7.5], 0.1 M NaCl, 8 mM MgSO4 · 7H2O, and 0.01% gelatin;
Sigma Aldrich, Gillingham, United Kingdom) and centrifuged at 13,000  g for
5 min to remove bacteria. The resulting supernatant was filtered through a
0.2-m-pore-size disposable filter (Minisart; Sartorius, Gottingen, Germany) to
remove any remaining bacteria. The filtrate was then applied to lawns of the
appropriate host C. jejuni prepared using a modification (2) of the method
described by Sambrook et al. (36). Primary isolates were selected on Campy-
lobacter host derived from the same sample or the C. jejuni reference stain NCTC
12662 (PT14). The plates were then incubated for 24 h at 42°C under microaero-
bic conditions. Plaques were extracted from the overlay using a pipette and
suspended in 100 l of SM medium. Single plaques were propagated in this way
a total of three times to ensure that the isolates represented a single clone.
Bacteriophages were amplified by using the plate lysis method (13). Stability of
phage titers at 4°C was determined over a 12-month period. Tolerance to dif-
ferent pH values from pH 2.2 to pH 9 was also explored by examining phage
titers after exposure and neutralization through the use of appropriate buffers.
Lytic profiles. The lytic activities of selected bacteriophages were determined
with 50 broiler chicken Campylobacter isolates and 80 reference strains of human
origin, whose phage type had been previously defined on the basis of the 16
bacteriophages currently in use in the United Kingdom phage typing scheme
(13). Lytic activity was assessed by pipetting 10 l containing log10 6 to 7 PFU
onto prepared bacterial lawns and allowing the phages to absorb into the overlay
agar. The plates were then incubated for 24 h at 42°C under microaerobic
conditions. If 20 plaques were produced from log10 6 to 7, the bacteria being
tested were regarded as being insensitive to the phages.
Enumeration of bacteriophages. Enumeration of bacteriophages were carried
out by making serial dilutions of the filtered suspensions of cecal and upper or
lower intestinal contents, prepared as described above. Each dilution of phage
suspension was applied as a 10-l spot in triplicate to the prepared bacterial lawn
and allowed to absorb into the overlay agar. Plates were incubated in the normal
way, and the number of plaques was counted on the appropriate dilutions giving
between 10 and 100 plaques to obtain the phage titer per gram for each section
of the chicken intestine sampled.
Examination of C. jejuni bacteriophages morphology by electron microscopy.
Bacteriophages CP8 and CP34 were examined by electron microscopy as previ-
ously described (2). Briefly, glutaraldehyde-fixed phage suspensions on Piolo-
form grids were negatively stained with 0.5% uranyl acetate. The specimens were
observed with a JEOL 100CX transmission electron microscope at an accelera-
tion voltage of 80 kV.
Phage genome size determination using PFGE. Genomic DNAs from bacte-
riophages CP8 and CP34 were prepared and run by using a CHEF DRII (Bio-
Rad, United Kingdom) as previously described (2). A 2-mm slice of each agarose
plug was inserted into the wells of a 1% agarose gel. The gel was run by using a
Bio-Rad CHEF DRII system in 0.5 Tris-borate-EDTA for 18 h at 6 V/cm with
a switch time of 30 to 60 s. Lambda concatemers (Sigma Aldrich, United King-
dom) were used as markers.
Bacteriophage DNAs. Genomic DNAs were prepared from each bacterio-
phage by using a standard protocol described for Lambda phage (36) using
proteinase K digestion followed by phenol-chloroform extraction and precipita-
tion. DNAs were digested with restriction enzymes (EcoRI, EcoRV, HhaI,
HindIII, PstI, and SspI; Promega, Ltd., Southampton, United Kingdom), and the
enzyme digests were run on a standard 0.6% Tris-acetate (0.04 M)-EDTA (0.001
M) buffer (pH 8.0) (36) agarose gel and stained with ethidium bromide after
electrophoresis. Random DNA fragments were produced by DNase I digestion
and repaired by using Klenow fragment and T4 DNA polymerases before mo-
lecular cloning as blunt-end fragments into the SmaI site of the plasmid vector
pUC8 (36). The pUC8 clones were sequenced to produce phage DNA sequences
from which prospective primer pairs were selected for PCR amplification in
order to produce DNA amplicons that would discriminate phage and Campy-
lobacter host DNAs (see additional information in the supplemental material).
DNA hybridization was performed by using the digoxigenin labeling system as
recommended by the supplier (Roche Diagnostics, Ltd., Lewes, United King-
dom).
In vitro experiments of phage efficacy. C. jejuni strain HPC5 was grown to
mid-exponential-growth phase in nutrient broth no. 2 (CM 67; Oxoid) under
microaerobic conditions in conical flasks on an orbital shaker. The cultures were
diluted in fresh medium to give approximately log10 5 CFU/ml, and bacterio-
phages (CP34 or CP8) were added to give multiplicities of infection (MOIs) of
0.1, 1, and 10. Accurate determinations of Campylobacter and bacterio-
phage counts were performed at the same time by serial dilution to give the
actual MOI of each experiment. Samples were taken over a period of 24 h.
Phage efficacy in chickens. Birds were infected with C. jejuni (HPC5 or GIIC8)
at 18 to 20 days old depending on the experimental protocol. Each bird received
log10 3 to 8 CFU Campylobacter in 1 ml of PBS by oral gavage. A Campylobacter-
free control group of bird were maintained for each experiment to ensure no
environmental infection was occurring. Bacteriophages CP34 or CP8 were ad-
ministered at 25 days old, once Campylobacter infection was established in
control birds. The bacteriophage doses of log10 5, 7, and 9 PFU were adminis-
tered in 1 ml of 30% (wt/vol) CaCO3 by oral gavage. Control groups of birds
(with or without Campylobacter) were administered with 30% (wt/vol) CaCO3 (1
ml) without bacteriophages. Birds were sacrificed at 24-h intervals, and the
numbers of both Campylobacter and phages in the cecal contents and the upper
and lower intestinal contents were enumerated. Colonization values are recorded
as the mean log10 Campylobacter count per gram of intestinal contents 	 the
standard deviation. The liver, pancreas, heart, and kidney were also dissected to
determine whether campylobacters and/or bacteriophages could be recovered
from homogenates of these tissues.
Statistical treatment of data. Interbird variance in control colonization levels
were examined by using log10-transformed Campylobacter counts using Bartlett’s
test (40). Statistical differences between paired control and treatment groups
(using log10-transformed Campylobacter counts) were assessed by using the Stu-
dent t test. Differences between experimental groups were analyzed by analysis of
variance.
Acquisition of phage resistance. In order to establish the frequency of resis-
tance to bacteriophages postintervention, 10 colonies from the isolation plates
from each phage-treated bird were selected and tested for resistance first to the
test phage they had been exposed to and subsequently a wider panel of bacte-
riophages used in the United Kingdom typing scheme (13). A bacterial lawn was
prepared from each colony pick, and the test bacteriophage was applied at a
range of dilutions from 0 to log10 6 PFU to establish whether resistance had been
acquired and to what degree. The in vitro frequency of phage resistance was also
determined in the same way from single colony Campylobacter isolates picked
from plates representing the 24-h time points of the growth experiments.
Stability of the resistant phenotype in vivo and in vitro. Resistant single-
colony isolates from both the in vitro and in vivo experiments were subcultured
on horse blood agar more than five times (representing more than 100 genera-
tions) and retested for resistance phenotype. In an experiment to determine the
stability of resistant phenotypes in vivo, resistant variants of HPC5 from the
CP34 treatment trial were selected (R14 and R20). Their colonization potential
was assessed by inoculation of a new batch of birds with these isolates. After 6
days the numbers of colonizing campylobacters in the cecal contents and upper
and lower intestines were determined as before. Single-colony isolates from
these birds were tested for their resistance phenotypes.
RESULTS
Selection of bacteriophages. Bacteriophages were isolated
from a range of sources, including broiler chicken excreta,
free-range layer-chicken excreta, and processed chicken meat
as described previously (2, 8). Bacteriophage isolates (n  53)
were selected for phage therapy trials on the basis of their ease
of propagation, maintenance of phage titers over time (stable
for 12 months at 4°C), and their stability at pH values be-
tween 4.0 and 9.0. All Campylobacter bacteriophage isolates
were inactivated at pH 2.2, a pH that they could experience
upon ingestion and transit of the proventriculus and gizzards of
birds. Two phage candidates were selected for further investi-
gation (CP8 and CP34) that exhibited the ability to lyse a range
of different campylobacters, including two characterized C.
jejuni hosts (HPC5 and GIIC8) that were subsequently utilized
in chicken colonization trials. Bacteriophages CP8 and CP34,
respectively, lysed 84 and 63 of 130 campylobacters tested
(these included 50 broiler chicken isolates collected from farms
at different geographic sites within the United Kingdom and
the 80 different phage types represented in the United King-
dom bacteriophage typing scheme). The phages CP8 and CP34
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were examined by electron microscopy (Fig. 1) and found to be
similar in structure, each possessing an icosahedral head (di-
ameters of 96 and 92 nm, respectively) and 100-nm contractile
tails with tail fibers at their distal end. These morphologies are
typical of the Myoviridae family of bacteriophages that exhibit
lytic lifestyles and are exemplified by T4 phage of E. coli.
Consistent with this, the genomic DNA sizes of each of these
phages were approximately 140 kb, as estimated by PFGE. CP8
and CP34 phage DNAs were refractory to the restriction en-
zymes EcoRI, EcoRV, HindIII, PstI, and SspI. However, the
restriction enzyme HhaI, which has previously been reported
to discriminate other Campylobacter bacteriophage DNAs, (2,
34), could cut CP8 but not CP34 genomic DNAs. Random
DNA fragments were generated from each of the phage DNAs
by using DNase I and cloned into the plasmid vector pUC8.
Despite the inherent difficulties in cloning phage DNAs, a
number of clones were obtained, and their DNA sequences
were determined. These DNA sequences were used to select
primer pairs that were designed to generate PCR amplicons
that could discriminate CP8 and CP34 bacteriophages. These
amplicons then formed the basis of a PCR-based method to
discriminate phage recovered from phage-treated chickens.
Chicken colonization model. We sought to create a model of
Campylobacter colonization of broiler chickens that could be
used specifically to evaluate the efficacy of phage therapy.
Low-passage C. jejuni isolates (subcultured less than four times
after isolation) from broiler chickens were initially screened
against a panel of lytic bacteriophages. Two isolates (C. jejuni
HPC5 and GIIC8) that were sensitive to infection by a broad
range of phages, including CP8 and CP34, were selected for
the colonization trials. The rate and level of colonization was
determined in 20- to 22-day-old birds. The age of the birds was
selected to parallel the first observation of colonization often
observed in commercial broiler chickens (25). The effect of
dose on the level of colonization of HPC5 (log10 2.7, 3.8, 5.8,
and 7.9 CFU) at 48 h is presented in Fig. 2A. The lowest doses
resulted in the greatest variance in Campylobacter colonization
of the small intestine, large intestine, and ceca. However, the
log10 7.9 doses resulted in reproducible colonization of all
intestinal sites examined at 48 h. To establish the persistence
and variation of the C. jejuni colonization levels over the ex-
perimental time frame, 20-day-old chickens were given a single
8-log10 CFU dose of C. jejuni, and the campylobacters enu-
merated from the intestinal contents of groups of these birds
killed at 24-h intervals. Figure 2B shows the colonization levels
of chickens following inoculation with C. jejuni HPC5 over a
7-day period. C. jejuni HPC5 could be detected in all parts of
the intestine within 24 h. Maximum colonization was achieved
within 48 h, and these colonization levels could be shown to be
maintained over 9 days (chickens at 22 to 30 days of age). From
48 h onward the log10 counts of C. jejuni per gram of cecal
contents showed equality of variance between all experimental
groups sampled at daily intervals (Bartlett’s test, P  0.05).
Mean viable counts and standard deviations of C. jejuni HPC5
in the upper intestine, lower intestine, and ceca were log10 6.3
	 0.8, 6.7 	 0.8, and 7.4 	 0.7 CFU/g of lumenal contents,
respectively. Similarly, time and dose responses were obtained
by using C. jejuni GIIC8, where the mean viable counts in the
upper intestine, lower intestine and ceca were log10 6.4 	 0.5,
8.0 	 0.4, and 7.8 	 0.4 CFU/g of lumenal contents, respec-
tively. Chickens colonized by these C. jejuni isolates did not
show invasion of any of the non-gastrointestinal-tract tissues
examined (liver, pancreas, heart, and kidney) throughout the
course of the experiment. These results indicated that HPC5
and GIIC8 were both able to colonize experimental birds
within the ranges of those reported for naturally infected birds
(33) and maintain colonization levels over a suitable time pe-
riod. The data collated from the colonization trials were sub-
sequently used to design the phage treatment experiments.
In vitro studies of phage efficacy. In vitro growth experi-
ments were carried out with phages CP8 and CP34 mixed with
C. jejuni host in liquid culture under microaerobic conditions
to give approximate MOIs of 0.1, 1, and 10. Bacteria and
phage were enumerated over a 24-h period. The growth of C.
jejuni host HPC5 and the replication of CP8 and CP34 are
presented in Fig. 3. Viable counts of the initial Campylobacter
inoculum and bacteriophage titer were performed to give the
actual values for the initial MOI, which for CP8 were 0.09, 6,
and 900 and for CP34 were 0.03, 3, and 300. Figure 3A to C
shows infection by bacteriophage CP8 of C. jejuni HPC5 at the
three different MOIs. Although the lowest MOI of 0.09 (Fig.
3A) resulted in the greatest reduction in Campylobacter counts
(log10 2) at the experimental end point of 24 h, the final
counts were within log10 0.5 for all three initial MOIs. At the
lowest MOI (0.09) the bacteriophage titers remained similar
for the first 12 h but increased rapidly over the second 12 h.
Bacteriophage applied at the highest MOI of 900 (Fig. 3C)
declined in numbers during the first 8 h but recovered to their
initial titer by the end of the experiment.
The replication of bacteriophage CP34 in C. jejuni HPC5
was markedly different to that of CP8. At the highest MOI (i.e.,
300) bacteriophage CP34 caused the numbers of campy-
lobacters to decline for 8 h (Fig. 3F), but after this time bac-
terial counts increased until they were log10 1 CFU below that
of the controls by 24 h. In contrast, the lowest MOI of 0.03 had
little effect on the growth of the bacteria until 8 h, but there-
after a reduction of log10 2 in Campylobacter count compared
to the control was observed. An MOI of 3 (Fig. 3E) was the
least effective dose at the 24-h sample point. Bacteriophage
enumeration of CP34 (Fig. 3D to F) revealed the highest MOI
of 300 to result in a decline in phage titer by more than log10
1 PFU/ml during the first 4 h, corresponding with a decline in
FIG. 1. Electron micrographs of bacteriophages CP8 (A) and CP34
(B). Bars, 0.1 m.
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numbers of host cells (Fig. 3F). Using the lowest MOI (0.03;
Fig. 3D) the phage titer increased over the first 4 h, while an
MOI of 3 (Fig. 3E) resulted in phage numbers remaining
relatively constant over the same period but increasing after
8 h. By 12 h, CP34 phages were approximately log10 6 PFU/ml
under all three experimental conditions and increased to log10
7 to 8 by 24 h regardless of the original MOI. The frequencies
of phage resistance after phage treatment were 8 and 11% for
CP8 and CP34, respectively. Subculturing these isolates five
times did not result in reversion to the sensitive phenotype.
Bacteriophage treatment of experimental chickens. Prelim-
inary experiments were performed to assess whether the use of
CaCO3 as an antacid was appropriate to protect the phages
from exposure to low pH during passage through the proven-
triculus and gizzard. Phages could be efficiently recovered from
the CaCO3 mixture and therefore was administered to control
chickens colonized with C. jejuni HPC5 or GIIC8. The control
birds remained colonized within the predetermined range for
each isolate, in all experiments. Host C jejuni HPC5 was used
to colonize chickens at 20 days of age and three different doses
of bacteriophage CP8 (log10 5, 7, and 9 PFU) administered
separately in antacid to birds 5 days after colonization. Figure
4A shows the effect of administering a log10 7 dose of CP8 on
the colonization levels of individual birds. The numbers of
campylobacters and bacteriophages in the intestinal contents
of the ceca and upper and lower intestine were determined and
FIG. 2. Colonization of Ross broiler chickens with C. jejuni HPC5. (A) Dose-dependent colonization of 21-day-old male Ross broiler chickens
with C. jejuni HPC5 (doses administered were log10 2.7, 3.8, 5.8, and 7.9 CFU). Colonization was assessed 48 h postinfection for each intestinal
site. (B) Colonization of Ross broiler chickens with C. jejuni HPC5 over a 7-day period. Chickens were administered at 20 days of age with log10
8 CFU.
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compared to the colonization levels in the control group re-
ceiving CaCO3 alone, and these were referenced to the values
established in the colonization model.
In common with all of the experimental phage treatments,
bacteriophage CP8 persisted over the course of the 5 days of
the trial with HPC5 C. jejuni-colonized birds. These observa-
tions indicated that the phages could be maintained with their
host within the chicken intestine. This may be compared to
phages administered to the control groups of non-C. jejuni-
colonized birds, within which phages were variably found in the
range of log10 3.5 to 4.1 PFU/g of intestinal contents after 24 h
and not at all thereafter. The phage titers recovered from
intestinal contents of HPC5 C. jejuni colonized chickens were
in the range of log10 3.2 to 6.5 PFU/g of cecal contents, which
are consistent with the distribution of phage titers detected in
the cecal contents of commercial broiler chickens naturally
colonized with phages (ranging between log10 3 and 6.9 PFU/g
of cecal contents with the mode at log10 4.2 PFU/g). The phage
titers recorded did not correlate with simple dilution of the
input dose, implying viral replication was occurring within 24 h
of administration. The non-gastrointestinal-tract tissues of
liver, pancreas, heart, and kidney were examined for the pres-
ence phages in these experiments, but none were recovered
from any bird.
Treatment of C. jejuni HPC5 colonized chickens with phage
CP34 at doses of 5, 7, and 9 log10 PFU resulted in significant
falls in Campylobacter counts at one or more of the three
intestinal sample sites during the course of the experiment.
Figure 4B shows the effect of administering a 7-log10 dose of
CP34 on the colonization levels of individual birds. Significant
falls in the cecal Campylobacter colonization levels were re-
corded for the 5- and 7-log10 PFU doses at 24 h after phage
administration. The highest phage dose of 9 log10 PFU did not
result in significant decreases in cecal Campylobacter coloniza-
FIG. 3. In vitro replication of phages CP8 and CP34 with host C. jejuni HPC5 using different phage inoculation doses. (A to C) Replication
of CP8 with initial MOIs of 0.09 (A), 6 (B), and 900 (C). F, Control Campylobacter count log10 CFU/ml; ■, Campylobacter count log10 CFU/ml
with phage; Œ, phage titer log10 PFU/ml. (D to F) Replication of CP34 with initial MOIs of 0.03 (D), 3 (E), and 300 (F) annotated as described
for panel A.
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FIG. 4. Comparison of the efficacy of CP8 and CP34 phages against C. jejuni HPC5 and GIIC8. Chickens colonized by C. jejuni HPC5 or GIIC8
were treated with a log10 7 PFU dose of either CP8 or CP34. E, Control Campylobacter counts of intestinal contents; F, bacteriophage-treated
Campylobacter counts (log10 CFU/g). (A) Phage CP8-treated chickens colonized with C. jejuni HPC5; (B) phage CP34-treated chickens colonized
with C. jejuni HPC5; (C) phage CP8-treated chickens colonized with C. jejuni GIIC8.
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tion levels in the early days of the experiment, but a significant
decrease of 1.4 log10 CFU/g (P  0.0007) was recorded on day
4 (results not shown). The most effective dose was log10 7 PFU
with respect to the decline in mean cecal Campylobacter
counts, with a drop to log10 3.9 CFU/g over the first 24 h
post-phage administration (P  0.012).
Overall, phage CP34 was more effective in the reduction of
C. jejuni at all intestinal sites compared to CP8. After the first
day of CP8 treatment, the Campylobacter counts fell in the
upper and lower intestines but the cecal counts were not sig-
nificantly different from the control birds.
A single log10 7 PFU dose of bacteriophage CP8 was admin-
istered to birds infected with C. jejuni GIIC8 (Fig. 4C). A
substantial decline in the mean numbers of campylobacters in
cecal contents of log10 5.6 CFU/g within 24 h of phage admin-
istration was observed with this phage-host combination (P 
0.00005). However, it is evident that the C. jejuni counts start
to recover from 72 h after phage administration. At 5 days after
phage treatment, the cecal and lower intestinal colonization
values still exhibit significant differences of log10 2.1 and 1.8
CFU/g, respectively, but the upper intestinal count had recov-
ered and to show no significant difference with the colonization
values recorded for the control group. It is clear that the
bacteriophage CP8 is much more effective in its ability to kill
the C. jejuni isolate GIIC8 than the HPC5 isolate in the
chicken intestine.
Acquisition of phage resistance in vitro and in vivo. Exam-
ination of single colony isolates of C. jejuni HPC5 that survived
CP34 phage infection in vitro revealed that 11% of these were
resistant to further CP34 infection. In contrast, 4% of the
single colony isolates recovered from broiler chickens post-
treatment with CP34 were resistant to the bacteriophage.
Spontaneous bacteriophage resistance was not detected in C.
jejuni reisolated from control chickens that were not exposed
to phages, where 10 independent colonies were selected and
tested from each control bird. Resistant C. jejuni strains from
phage-treated birds were confirmed to be congruous to the
original strain by MLST (sequence type 356). This was neces-
sary to ensure that cross-contamination with different strains of
Campylobacter had not occurred. Two independent phage re-
sistant isolates of HPC5 (R14 and R20) were selected from two
independent phage-treated birds and examined for the pres-
ence of CP34 phage DNA in their genomic DNAs. DNA hy-
bridization of R14 and R20 genomic DNAs against digoxige-
nin-labeled phage DNA did not produce a hybridization signal
and PCR amplification with phage-specific primers using R14
and R20 genomic DNAs as a template did not produce a
positive amplicon. The phage-resistant isolates R14 and R20
were further tested in the colonization model and compared to
the original strain. The average cecal contents Campylobacter
counts were log10 6.2 	 0.98 CFU/g for R14 and 5.9 	 0.68
CFU/g for R20. This was compared to the model colonization
level of log10 6.8 	 0.3 CFU/g, which was significantly higher
than R20 (P  0.02) but not R14 (P  0.13). Ninety isolates
from birds initially colonized with either R20 or R14 were
retested for a phage-resistant phenotype; of these, 97% were
found to have reverted back to a phage-sensitive phenotype.
These isolates were again confirmed as being genotypically
derived from the original isolate by MLST.
DISCUSSION
Before adopting bacteriophage therapy as a means of con-
trolling campylobacters in broiler chickens, it is important to
understand the dynamics of bacteriophage infection in exper-
imental birds that are typical of commercial breed stock and
colonized by appropriate host C. jejuni strains (25). We there-
fore considered it important to demonstrate that the C. jejuni
selected for the present study could establish and maintain
colonization, such that any changes in Campylobacter coloni-
zation could be ascribed to the introduction of phage. Our data
confirm that the C. jejuni isolates were maintained in the ex-
perimental chickens over a 9-day period (21- to 30-day-old
birds) and that the levels of Campylobacter are consistent with
those reported for naturally colonized chickens, which are in
the range of log10 4.0 to log10 8.0 CFU/g of cecal contents (33).
Experimental bacteriophage treatments of C. jejuni-colonized
birds resulted in phage titers persisting over the course of the
trial implying that the phages administered were delivered to
the intestinal sites colonized by C. jejuni and were able to
replicate within the environment of the chicken intestinal tract.
Chickens possess a pair of ceca at the junction of the ileum and
rectum. The ceca represent a reservoir of microbes off the
main gastrointestinal tract, where microflora actively enter the
ceca by retrograde peristalsis of digesta that are not dis-
charged.
The kinetics of bacteriophage replication and host growth
were examined in vitro in order to gauge the course of infec-
tion and provide a basis on which to select the most suitable
bacteriophages for subsequent in vivo experiments. The high-
est dose applied (MOI 10) was intended to examine whether
campylobacters could be reduced by passive inundation (28).
Passive inundation refers to where bacterial numbers are de-
pleted by the attachment of overwhelming numbers of phage
but without productive replication of the bacteriophage. The
lower phage doses (MOI  1) were expected to initiate active
proliferation of the phage and bacteria, with the phage even-
tually overwhelming their host. The former was initially con-
sidered as an appropriate strategy for the phage treatment of
chickens from the point of view of reducing the possibility of
acquired host resistance to phages over time. The low dose
with active replication of phage is the scenario that is probably
most similar to the primary entry of phages into the intestinal
tract of Campylobacter colonized chicken flock. However, once
an individual bird within the flock has been colonized by
phage, all subsequent birds are likely to be exposed to higher
doses as the phage are shed.
It was clear from our in vitro experiments that CP8 and
CP34 bacteriophages exhibited some fundamental differences
in their ability to predate the host HPC5. Comparison of these
two phages in vitro with the same host over a comparable
range of MOI revealed CP8 to be the most effective phage with
respect to the reduction in the Campylobacter viable count at
the experimental end point (24 h). Although phage-resistant
variants could be isolated at this point the majority of the
Campylobacter population remained sensitive to phage. Bacte-
ria encountering high phage densities may be “lysed from with-
out” leading to large quantities of bacterial cell debris to which
phages may adhere in competition with live bacterial cells (30).
This may lead to an initial drop in titer as many of the phages
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are unable to replicate. Under conditions where high initial
MOIs of CP8 and CP34 phages were applied to C. jejuni
HPC5, the phage titer was observed to fall, possibly due to
nonproductive binding as described above. However, in con-
trast to CP8, phage CP34 had recovered some of the initial fall
in titer by 8 h due to its tendency to replicate earlier.
After the in vitro experiments, the same phage and host
combinations were tested in chickens. The ability of bacterio-
phage CP34 to replicate on the C. jejuni host HPC5 in chickens
resulted in significant reductions in the cecal Campylobacter
counts with doses of log10 5 and log10 7 PFU, but log10 9 PFU
was less effective. Phages were evident in the ceca of the log10
9 PFU-treated birds, so why they were ineffective in bringing
about a reduction in the Campylobacter population is not clear.
The first encounter of the phages administered with metabol-
ically active host C. jejuni is likely to occur in the upper reaches
of the intestinal tract and could influence the subsequent
course of the treatment. The adherence of the phages to host
bacterial cells leading to cell death without phage replication
will effectively diminish the dose carried to later sections of the
gut. Higher phage densities are also prone to phage aggrega-
tion and nonspecific association with digesta or non-host bac-
teria (30).
In general, bacteriophage CP 8 was less effective than CP34
against C. jejuni HPC5 colonizing broiler chickens. The pre-
ceding in vitro experiments and the recovery of CP8 from
phage-treated chickens over 5 days clearly indicates that CP8 is
able to replicate on C. jejuni HPC5 but not appreciably reduce
C. jejuni HPC5 populating the chicken intestinal tract. The
superior ability of bacteriophage CP34 over CP8 to kill C.
jejuni HPC5 in chickens is contrary to the observations in vitro,
which would clearly favor the ability of CP8. However, despite
the inability of CP8 to affect C. jejuni HPC5 in chickens, the
treatment of chickens with the same bacteriophage but colo-
nized with an alternative host, C. jejuni GIIC8, yielded a
log10 5 reduction in cecal Campylobacter counts. The greatest
reductions in cecal Campylobacter counts were observed at 24
and 48 h after phage treatment, after which the Campylobacter
counts recovered to a level of log10 2 less than the control
chickens over the next 3 days. Phage CP8 clearly has the ca-
pacity to function as a therapeutic agent in chickens, where it
survived ingestion, discriminated nonspecific materials, and
encountered enteric defense mechanisms, but was still able to
replicate in the intestinal tract. Therefore, the lack of success
of this phage with C. jejuni HPC5 is intriguing; at least a
proportion of the host must remain permissive and accessible,
since C. jejuni HPC5 can support the propagation of phage
CP8 over the 5 days of the experiment. It is possible that a
subpopulation of bacteria may become resistant to the phage
CP8, but currently there is no evidence for this in the bacteria
recovered after phage treatment. However, if the resistance
was transient, say, for a population of bacteria that were phys-
iologically downshifted and capable of regrowth, then the bac-
teria would escape the phage but remain fundamentally phage
sensitive. Alternatively, a proportion of the C. jejuni HPC5
population may colonize intestinal sites that are either inac-
cessible for or a hindrance to CP8 attachment. For example,
close proximity to the intestinal mucosa.
The avian intestinal tract is a complex environment where
various physical (for example, the constant flow of digesta and
mixing with non-host bacteria) and physiological (for example,
oxygen levels) host defenses and biochemical factors (such as
proteolytic enzymes and adverse pH) all influence the popu-
lations of colonizing bacteria. In addition, the kinetics of phage
adsorption in the intestine may be quite different from labo-
ratory media due to the viscosity of the mucus layer (42). It is
evident that the direct translation information gained from
homogeneous bacteria and phages in a well-mixed and con-
trolled laboratory environment to the situation in vivo is not
going to be a reliable measure of the efficacy of the phage to
kill host bacteria.
The selection of resistant bacteria has always been perceived
as a potential drawback to phage therapy and has been re-
ported following phage treatment (37–39). However, resis-
tance can be correlated with reduced virulence (27, 39). Here
the incidence of phage-resistant phenotypes after phage chal-
lenge did not become the dominant population in phage-
treated chickens despite the continued presence and replica-
tion of these phages. Chickens subject to environmental
challenge will encounter diverse Campylobacter genotypes, it is
therefore more likely that succession by phage insensitive ge-
notypes will occur rather than through the selection of phage
resistant strains (8). In the present study we have elected to use
a single phage in each experiment to provide comparative data
between phages. However, in commercial production it might
be necessary to administer a cocktail of phages.
These data represent the first steps toward an understanding
of the kinetic processes and the characteristics of Campy-
lobacter bacteriophages that are necessary if the potential of-
fered by phage therapy as a sustainable biological control mea-
sure is to be harnessed for the reduction of campylobacters
emanating from farmed poultry sources.
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